Showing results (71-80 of 566) with videos related to

Sort By:
Pageof 57
Leber, Magen, Darm|October 1, 1977
[Cytostatic therapy of gastro-intestinal carcinomas (author's transl)]V Diehl
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1994
Controversies in terminal cancer careV Diehl
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Fractionated chemotherapy--granisetron or conventional antiemetics? The Granisetron Study GroupV Diehl
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2002
Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's diseaseA Josting, C Rudolph, M Reiser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSGU Rueffer, M Sieber, A Josting, et al.
Cytokines and Molecular Therapy|September 1, 1996
A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell linesA Klimka, S Barth, S Drillich, et al.
Annals of Hematology|May 25, 2002
Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemiaT Pfitzner, M Reiser, S Barth, et al.
Annals of Hematology|August 12, 2003
Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trialJ-P Glossmann, A Engert, G Wassmer, et al.
British Journal of Cancer|June 22, 1999
An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell lineA Klimka, S Barth, B Matthey, et al.
Bone Marrow Transplantation|July 22, 1999
Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationM Reiser, A Josting, A Draube, et al.
Pageof 57